You have 9 free searches left this month | for more free features.

Theranostics

Showing 1 - 25 of 76

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

High Grade Glioma Trial (177Lu-PSMA I&T)

Not yet recruiting
  • High Grade Glioma
  • 177Lu-PSMA I&T
  • (no location specified)
Dec 1, 2022

Imageguided Theranostics in Multiple Myeloma

Completed
  • Cancer
  • Myeloma
    • Sutton, Surrey, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Dec 13, 2022

    Soft Tissue Sarcoma Trial (Ga-68-PSMA-11 PET/CT, Lu-177-ITG-PSMA-1)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • (no location specified)
    Jul 7, 2022

    Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Melbourne (177Lu-PSMA)

    Recruiting
    • Prostate Cancer
    • Metastatic Castration-resistant Prostate Cancer
    • 177Lu-PSMA
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Mar 28, 2022

    Neuroendocrine Tumors Trial in New York (PET/CT Imaging, 68Ga-DOTA-JR11, 177Lu-DOTA-JR11)

    Completed
    • Neuroendocrine Tumors
    • PET/CT Imaging
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2022

    Acute Myocardial Infarction Type 1 Trial in Indianapolis (Deferiprone Tablets, Placebo)

    Recruiting
    • Acute Myocardial Infarction Type 1
    • Deferiprone Tablets
    • Placebo
    • Indianapolis, Indiana
      Krannert Cardiovascular Research Center
    Dec 14, 2022

    Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • LS301-IT 0.025 mg/kg
    • +3 more
    • Scottsdale, Arizona
      Integro Theranostics Research Site #1
    Jun 2, 2023

    Well-Being, Psychological, Biomarkers, Cancer Trial in Coimbra (Hosting conditions, Hospital Clowns)

    Completed
    • Well-Being, Psychological
    • +4 more
    • Hosting conditions
    • Hospital Clowns
    • Coimbra, Portugal
    • +2 more
    Nov 15, 2023

    Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

    Not yet recruiting
    • Carcinoid Tumor Lung
    • +2 more
    • 212-Lead Pentixather
    • 203-Lead Pentixather SPECT/CT
    • Iowa City, Iowa
      The University of Iowa Theranostics Center
    Sep 23, 2022

    Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

    Recruiting
    • Thyroid Cancer, Medullary
    • +3 more
    • Basel, Switzerland
      University Hospital Basel, Clinic for radiology and nuclear medi
    May 23, 2022

    Multiple Myeloma Trial in Beijing (68Ga-Pentixather, 68Ga-Pentixafor)

    Recruiting
    • Multiple Myeloma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 3, 2022

    Healthy Volunteers, Pancreatic Ductal Adenocarcinoma Trial (RAD301 ([68Ga]-Trivehexin))

    Not yet recruiting
    • Healthy Volunteers
    • Pancreatic Ductal Adenocarcinoma
    • RAD301 ([68Ga]-Trivehexin)
    • (no location specified)
    Mar 22, 2023

    Solid Tumor, Lymphoma Trial in Los Angeles (DZ-002)

    Recruiting
    • Solid Tumor
    • Lymphoma
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Mar 2, 2022

    Myofascial Pain Syndrome Trial in Ávila (Sonoelastography, tensiomyography and mechanosensitivity)

    Completed
    • Myofascial Pain Syndrome
    • Sonoelastography, tensiomyography and mechanosensitivity
    • Ávila, Spain
      Universidad Católica de Ávila
    Mar 16, 2023

    Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis Trial in Los Angeles (68Ga-FAPi-46,

    Recruiting
    • Interstitial Lung Disease
    • +6 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    May 6, 2022

    Thyroid Disease Trial in Syracuse (SPECT)

    Enrolling by invitation
    • Thyroid Disease
    • SPECT
    • Syracuse, New York
      SUNY Upstate Medical University
    Aug 31, 2023

    CKD Trial in Nanjing (Fecal Microbiota Transplantation, Standard of Care for Chronic Kidney Disease)

    Recruiting
    • CKD
    • Fecal Microbiota Transplantation
    • Standard of Care for Chronic Kidney Disease
    • Nanjing, Jiangsu, China
      the Second Affiliated of Nanjing Medical University
    Apr 20, 2023

    Keratoconus Trial in Catanzaro, Firenze, Messina (Riboflavin/UV-A corneal cross-linking)

    Recruiting
    • Keratoconus
    • Riboflavin/UV-A corneal cross-linking
    • Catanzaro, Italy
    • +2 more
    Jul 13, 2022

    Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

    Not yet recruiting
    • Cancer
    • [177Lu]Lu-PSMA I&T
    • Meldola, Forlì, Italy
    • +1 more
    May 10, 2023

    Hypoplastic Left Heart Syndrome Trial in United States (Autologous (self) mononuclear cells derived from umbilical cord blood,

    Active, not recruiting
    • Hypoplastic Left Heart Syndrome
    • Autologous (self) mononuclear cells derived from umbilical cord blood
    • Stage II Surgical repair
    • Birmingham, Alabama
    • +7 more
    Jan 9, 2023

    Glioma, Malignant Trial in London (PET-MRI, Brain tumour biopsy)

    Not yet recruiting
    • Glioma, Malignant
    • PET-MRI
    • Brain tumour biopsy
    • London, United Kingdom
      King's College London
    Jun 8, 2022

    Plexin D1 as a Potential Biomarker inPM/DM

    Not yet recruiting
    • Polymyositis
    • Dermatomyositis
    • plexinD1
    • (no location specified)
    Nov 25, 2022

    Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (90Y-DOTA-tyr3-Octreotide, Dosimetry-Guided Peptide

    Unknown status
    • Neuroendocrine Tumors
    • +3 more
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Apr 25, 2019

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • [212Pb] VMT-α-NET
    • [203Pb] VMT-α-NET SPECT/CT
    • Iowa City, Iowa
      Holden Comprehensive Cancer Center at the University of Iowa
    Nov 30, 2023